Signals
ASCO 2026: Are we overtreating cancer?
The biggest oncology story in Chicago was not only who needs more treatment. It was who may safely need less.
Lung Cancer Screening Now Has a Diagnostic Bottleneck
Liquid Biopsy Turns Precision Oncology Into an NHS Delivery Test
Molecular Testing Is Europe’s Real Precision Oncology Infrastructure
Cancer Approval Is No Longer Enough
Europe’s Cancer Inequality Map Becomes a Performance Test
Europe’s Cancer Projects Start Looking Like Delivery Infrastructure
EU Cancer Policy Moves Back Into Budget Politics
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.